Champions Oncology Investor Relations Material
Latest events
Q4 2025
Champions Oncology
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Champions Oncology Inc
Access all reports
Champions Oncology, Inc. is a technology-driven research organization that provides preclinical and clinical solutions to support drug development in the pharmaceutical and biotechnology industries. The company specializes in oncology-focused services, including patient-derived xenograft (PDX) models, biomarker discovery, and data analytics. The company is headquartered in Hackensack, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
CSBR
Country
🇺🇸 United States